Cite
HARVARD Citation
Cedena, M. et al. (n.d.). Mutations in DNA Methylation Pathway and Number of Driver Mutations Predict Response to Azacitidine in Myelodysplastic Syndromes. Leukemia research. pp. S61-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cedena, M. et al. (n.d.). Mutations in DNA Methylation Pathway and Number of Driver Mutations Predict Response to Azacitidine in Myelodysplastic Syndromes. Leukemia research. pp. S61-. [Online].